Aardvark Therapeutics, Inc. Common Stock
USD5.67
+0.49 (+9.56%)
CEO
Tien-Li Lee
IPO Date
2025-02-13
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$5.19
Prev. Close
$5.18
Day Low
$5.05
Day High
$5.69
52W Low
$3.35
52W High
$17.94
Market Cap
$0.12B
Volume
0.15M
| -15.1 |
| 31 Dec 2023 | FY | 0.0% | 0.0% | 20.7% | -68.4% | -0.00 | 7.50 | -42.5 |
| 31 Dec 2022 | FY | 0.0% | 0.0% | 48.6% | -80.9% | -0.01 | 27.72 | -22.6 |
| -4.1 |
| 30 Sept 2025 | Q3 | 0.0% | 0.0% | -13.3% | -12.2% | 0.00 | 12.03 | -4.4 |
| 30 Jun 2025 | Q2 | 0.0% | 0.0% | -10.5% | -9.7% | 0.00 | 14.04 | -5.1 |
| 31 Mar 2025 | Q1 | 0.0% | 0.0% | -6.2% | -5.9% | 0.00 | 25.86 | -4.4 |
| 31 Dec 2024 | Q4 | 0.0% | 0.0% | 16.1% | -11.3% | -0.01 | 15.05 | -8.8 |
| 30 Sept 2024 | Q3 | 0.0% | 0.0% | 9.1% | -5.0% | -0.02 | 31.65 | -18.3 |
| 30 Jun 2024 | Q2 | 0.0% | 0.0% | 12.9% | -6.2% | -0.00 | 32.67 | -14.0 |
| 31 Mar 2024 | Q1 | 0.0% | 0.0% | 0.0% | 0.0% | 0.00 | 0.00 | -35.1 |
| 31 Dec 2023 | Q4 | 0.0% | 0.0% | 5.9% | -19.4% | -0.00 | 7.50 | -37.5 |